These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 36502405)

  • 1. Past as Prologue-Use of Rubella Vaccination Program Lessons to Inform COVID-19 Vaccination.
    Dixon MG; Reef SE; Zimmerman LA; Grant GB
    Emerg Infect Dis; 2022 Dec; 28(13):S225-S231. PubMed ID: 36502405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Considerations for Establishing Successful Coronavirus Disease Vaccination Programs in Africa.
    Williams V; Edem B; Calnan M; Otwombe K; Okeahalam C
    Emerg Infect Dis; 2021 Aug; 27(8):2009-2016. PubMed ID: 34138694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Effectiveness of Global COVID-19 Vaccination Campaign.
    He D; Ali ST; Fan G; Gao D; Song H; Lou Y; Zhao S; Cowling BJ; Stone L
    Emerg Infect Dis; 2022 Sep; 28(9):1873-1876. PubMed ID: 35914516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measles, mumps, rubella prevention: how can we do better?
    Kauffmann F; Heffernan C; Meurice F; Ota MOC; Vetter V; Casabona G
    Expert Rev Vaccines; 2021 Jul; 20(7):811-826. PubMed ID: 34096442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Research priorities for accelerating progress toward measles and rubella elimination identified by a cross-sectional web-based survey.
    Kriss JL; Grant GB; Moss WJ; Durrheim DN; Shefer A; Rota PA; Omer SB; Masresha BG; Mulders MN; Hanson M; Linkins RW; Goodson JL
    Vaccine; 2019 Sep; 37(38):5745-5753. PubMed ID: 30898393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical study of safety and immunogenicity of combined rubella and human papillomavirus vaccines: Towards enhancing vaccination uptake rates in developing countries.
    Gohar A; Abdeltawab NF; Shehata N; Amin MA
    Papillomavirus Res; 2019 Dec; 8():100172. PubMed ID: 31185296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiological profile and progress toward rubella elimination in China. 10 years after nationwide introduction of rubella vaccine.
    Su Q; Ma C; Wen N; Fan C; Yang H; Wang H; Yin Z; Feng Z; Hao L; Yang W
    Vaccine; 2018 Apr; 36(16):2079-2085. PubMed ID: 29550193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDC's COVID-19 International Vaccine Implementation and Evaluation Program and Lessons from Earlier Vaccine Introductions.
    Soeters HM; Doshi RH; Fleming M; Adegoke OJ; Ajene U; Aksnes BN; Bennett S; Blau EF; Carlton JG; Clements S; Conklin L; Dahlke M; Duca LM; Feldstein LR; Gidudu JF; Grant G; Hercules M; Igboh LS; Ishizumi A; Jacenko S; Kerr Y; Konne NM; Kulkarni S; Kumar A; Lafond KE; Lam E; Longley AT; McCarron M; Namageyo-Funa A; Ortiz N; Patel JC; Perry RT; Prybylski D; Reddi P; Salman O; Sciarratta CN; Shragai T; Siddula A; Sikare E; Tchoualeu DD; Traicoff D; Tuttle A; Victory KR; Wallace A; Ward K; Wong MKA; Zhou W; Schluter WW; Fitter DL; Mounts A; Bresee JS; Hyde TB
    Emerg Infect Dis; 2022 Dec; 28(13):S208-S216. PubMed ID: 36502382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measles and Rubella Global Strategic Plan 2012-2020 midterm review report: Background and summary.
    Orenstein WA; Cairns L; Hinman A; Nkowane B; Olivé JM; Reingold AL
    Vaccine; 2018 Jan; 36 Suppl 1():A35-A42. PubMed ID: 29307368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in measles and rubella elimination in Iran.
    Esteghamati A; Gouya MM; Zahraei SM; Dadras MN; Rashidi A; Mahoney F
    Pediatr Infect Dis J; 2007 Dec; 26(12):1137-41. PubMed ID: 18043452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leveraging Lessons Learned from Yellow Fever and Polio Immunization Campaigns during COVID-19 Pandemic, Ghana, 2021.
    Amponsa-Achiano K; Frimpong JA; Barradas D; Bandoh DA; Kenu E
    Emerg Infect Dis; 2022 Dec; 28(13):S232-S237. PubMed ID: 36502407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strengthening routine immunization through measles-rubella elimination.
    Biellik RJ; Orenstein WA
    Vaccine; 2018 Sep; 36(37):5645-5650. PubMed ID: 30041881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expansion of Vaccination Services and Strengthening Vaccine-Preventable Diseases Surveillance in Haiti, 2010-2016.
    Tohme RA; Francois J; Cavallaro KF; Paluku G; Yalcouye I; Jackson E; Wright T; Adrien P; Katz MA; Hyde TB; Faye P; Kimanuka F; Dietz V; Vertefeuille J; Lowrance D; Dahl B; Patel R
    Am J Trop Med Hyg; 2017 Oct; 97(4_Suppl):28-36. PubMed ID: 29064356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'Learn from the lessons and don't forget them': identifying transferable lessons for COVID-19 from meningitis A, yellow fever and Ebola virus disease vaccination campaigns.
    Collins J; Westerveld R; Nelson KA; Rohan H; Bower H; Lazenby S; Ikilezi G; Bartlein R; Bausch DG; Kennedy DS
    BMJ Glob Health; 2021 Sep; 6(9):. PubMed ID: 34535490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innovations in vaccine delivery: increasing access, coverage, and equity and lessons learnt from measles and rubella elimination.
    Goodson JL; Rota PA
    Drug Deliv Transl Res; 2022 May; 12(5):959-967. PubMed ID: 35211868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of rapid coverage monitoring in the national rubella vaccination campaign, Haiti 2007-2008.
    Lacapère F; Magloire R; Danovaro-Holliday MC; Flannery B; Chamoulliet H; Celestin EP
    J Infect Dis; 2011 Sep; 204 Suppl 2():S698-705. PubMed ID: 21954269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress in Rubella and Congenital Rubella Syndrome Control and Elimination - Worldwide, 2000-2016.
    Grant GB; Reef SE; Patel M; Knapp JK; Dabbagh A
    MMWR Morb Mortal Wkly Rep; 2017 Nov; 66(45):1256-1260. PubMed ID: 29145358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Informing rubella vaccination strategies in East Java, Indonesia through transmission modelling.
    Wu Y; Wood J; Khandaker G; Waddington C; Snelling T
    Vaccine; 2016 Nov; 34(46):5636-5642. PubMed ID: 27670077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Making vaccination policy: the experience with rubella.
    Parkman PD
    Clin Infect Dis; 1999 Jun; 28 Suppl 2():S140-6. PubMed ID: 10447033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leveraging HIV Program and Civil Society to Accelerate COVID-19 Vaccine Uptake, Zambia.
    Bobo P; Hines JZ; Chilengi R; Auld AF; Agolory SG; Silumesii A; Nkengasong J
    Emerg Infect Dis; 2022 Dec; 28(13):S244-S246. PubMed ID: 36502463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.